Radomír Taláb, Marika Talábová
Adherence to treatment or compliance with treatment is a big problem, which applies approximately to 50 up to 60%
of chronically ill patients. Adherence to treatment of sclerosis multiplex (SM) is a significant aspect of treatment and
care for these patients and undoubtedly has an impact on therapeutical results and its prognosis. Adherence to treatment
is determined by many factors: dosage form, the frequency of administration, treatment effectiveness, its longterm
safety and tolerance, awareness of adverse effects and its solving by a doctor, patient’s confidence and control of
compliance with treatment. Differences in adherence occur in adults and children. The patient’s condition and self-sufficiency,
surrounding, hope for future and support by medical staff belong to predictors of adherence in SM.